Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
CareCloud ( (CCLD) ) has issued an announcement.
On August 22, 2025, CareCloud, Inc. completed the acquisition of Medsphere Systems Corporation, a provider of inpatient and ambulatory solutions, thereby expanding its reach into the hospital IT market. This strategic acquisition is expected to offer affordable, scalable solutions to small and mid-sized hospitals, enhancing CareCloud’s position in the healthcare industry by integrating Medsphere’s technology with its AI capabilities to improve patient care and operational efficiency.
The most recent analyst rating on (CCLD) stock is a Hold with a $3.00 price target. To see the full list of analyst forecasts on CareCloud stock, see the CCLD Stock Forecast page.
Spark’s Take on CCLD Stock
According to Spark, TipRanks’ AI Analyst, CCLD is a Neutral.
CareCloud’s overall stock score reflects a stable financial position with strong cash flow and a solid balance sheet, despite challenges in revenue growth. The technical analysis supports a positive outlook with bullish momentum. The earnings call provided positive insights into the company’s strategic direction and operational achievements. However, the negative P/E ratio and lack of dividend yield weigh on the valuation score, impacting the overall assessment.
To see Spark’s full report on CCLD stock, click here.
More about CareCloud
CareCloud, Inc. is a leader in healthcare technology and AI-powered solutions, providing services such as revenue cycle management, practice management, electronic health records, business intelligence, patient experience management, and digital health. The company supports over 40,000 providers in enhancing patient care while reducing administrative burdens and operating costs.
Average Trading Volume: 356,793
Technical Sentiment Signal: Hold
Current Market Cap: $119.8M
For a thorough assessment of CCLD stock, go to TipRanks’ Stock Analysis page.